Isaac Bentwich, MD, is the Founder and CEO of Quris Technologies Ltd., a groundbreaking company focused on revolutionizing drug development through its innovative Bio-AI Clinical Prediction Platform. Leveraging a disruptive bio-AI approach, Quris analyzes the human genome to identify novel microRNA genes, exceeding the combined output of all universities globally. This approach is extended to drug development, utilizing Patients-on-a-Chip to create an extensive proprietary dataset for machine learning models. By testing known safe and unsafe drugs on miniaturized Patients-on-a-Chip and applying classification algorithms, Quris aims to predict drug candidates' clinical safety and efficacy more accurately, addressing the challenges faced by traditional pre-clinical data methods.